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Abstract 
 
 
 
A NOVEL METHOD TO DETECT FUNCTIONAL SUBGRAPHS IN BIOMOLECULAR 
NETWORKS 
 
 
Sterling Wells Thomas, Doctor of Philosophy 
 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor 
of Philosophy at Virginia Commonwealth University 
 
Virginia Commonwealth University, 2010 
 
Danail Bonchev, Ph.D., Sc.D., Senior Fellow, Professor and Director of Research on 
Bioinformatics, Center for the Study of Biological Complexity 
 
 
Several biomolecular pathways governing the control of cellular processes have been 
discovered over the last several years. Additionally, advances resulting from combining 
these pathways into networks have produced new insights into the complex behaviors 
observed in cell function assays. Unfortunately, identification of important sub-networks, 
or “motifs”, in these networks has been slower in development. This study focused on 
identifying important network motifs and their rate of occurrence in two different 
biomolecular networks. The two networks evaluated for this study represented both 
ends of the spectrum of interaction knowledge by comparing a well defined network 
(apoptosis) with and poorly studied network that was early in development (autism). 
This study identified several motifs that could be important in governing and controlling 
cellular processes in healthy and diseased cells. Additionally, this study revealed an 
inverse relationship when comparing the occurrence rate of these motifs in apoptosis 
and autism.   
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Chapter 1: Introduction 
 
Over the past decade scientists have discovered many genetic/molecular 
pathways responsible for the control of cellular processes. The purpose of this 
control is to activate or deactivate processes responsible for specific functions in 
the cell that are critical for cell survival, but not needed during the every step of 
the cell cycle. These cellular functions under control include cell cycle 
progression and division, DNA damage repair, apoptosis, synthesis and many 
more. Additionally, the controlling pathways for these functions have a 
significantly higher rate of mutation or deletion in solid malignant tumors. 
Resulting from the discovery of signaling pathways and their high rate of 
mutation and deletion, many new diagnostic and therapeutic studies are focused 
on testing and repairing these signaling networks. One of the major challenges of 
these studies is identifying all the networks formed by overlapping and redundant 
signaling pathways commonly found in Homo sapiens. During my preliminary 
studies it has been observed that biomolecular networks responsible for signaling 
and control of apoptosis include several closely related proteins termed slave 
that have similar functions but competitively suppress the activation of a 
controlling protein (termed master). The slave/master proteins thus form a 
redundant activation system that is resistant to minor mutations or deletions.  
The hypothesis of this thesis is a master/slave arrangement in signaling 
and regulatory networks represents a specific network motif that can be used to 
identify other signaling and controlling networks as targets for diagnostics or 
therapeutics. 
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Figure 1 - Visual model of ideal master/slave relationship described in the hypothesis. 
 
The following four stages of this study will aid in verifying motifs are 
influenced by both evolutionary pressures and functional pressures and whether 
this hypothesis holds true. 
Stage 1: Construct a network of cellular gene/protein agents and potential 
molecular regulatory pathways specific for apoptosis including the integrated 
Bcl2 family of genes and proteins from interactions reported in BioGRID, Cancer 
Cell Map, Human Protein Reference Database, IntAct, MINT, NCI/Nature 
Pathway Interaction and Reactome databases. Network nodes and interactions 
will be identified using mRNA expression data from gene arrays based on whole-
blood samples from individuals diagnosed with adenocarcinoma of the lung 
obtained from the Oncomine and Gene Expression Omnibus (GEO) databases. 
 
Stage 2: Model and simulate Bcl2 family genes and protein networks to identify 
subgraphs using cellular automata driven agent-based modeling. Calculate 
topological measures of the discovered subgraphs to identify those that follow 
the hypothesized master and slave node model. Topological measures include 
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but are not limited to connectivity (Zagreb M2 and Betweenness), node degree, 
number of second neighbor nodes (k1 and k2), number of first and second 
neighbor edges (A(k)). Develop a mathematical model describing the 
hypothesized relationship to be used in Stage 3 and 4. 
 
Stage 3: Identify a differential network of cellular gene/protein agents and 
potential gene regulatory pathways specific for functional changes associated 
with the progression of adenocarcinoma of the lung. Network nodes and 
interactions will be identified using mRNA expression data from gene arrays 
based on whole-blood samples from individuals diagnosed with adenocarcinoma 
of the lung obtained from the Oncomine and Gene Expression Omnibus (GEO) 
databases. Identify networks subgraphs that follow the proposed hypothesis. 
 
Stage 4: Identify a differential network of cellular gene/protein agents and 
potential gene regulatory pathways specific for functional changes associated 
with the progression of Autism Spectrum Disorder (ASD). Network nodes and 
interactions will be identified using mRNA expression data from gene arrays 
based on whole-blood samples from individuals diagnosed with ASD and 
obtained from the Autism Genome Resource Exchange (AGRE). Topological 
analysis will be limited to identification of subgraphs that follow the hypothesized 
functional structure from Aim 1. 
 
Significance: 
 
Lung Adenocarcinoma is the most common Non Small Cell Lung Cancer NSCLC 
and is the most common lung cancer among in life-long non-smokers. Lung 
cancer occurs in 62.5 of every 100,000 men and women in the United States, 
and is one of the most common occurring cancers (SEER).  Lung Cancer 
commonly metastasizes and is found distally at diagnosis in 56% of patents.  
Lung Cancer detected distally at diagnosis has a 5-year survival rate only of 
3.5% (SEER). Adenocarcinoma accounts for 40% of the tumors at diagnosis and 
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represents a significant challenge to the United States medical community.  The 
average age at diagnosis is 71 years, and although occurrence has recently 
declined by 0.8%, is expected to increase with the aging “Baby-Boomer” 
generation. 
The Genetic Epidemiology of Lung Cancer Consortia 
(http://epi.grants.cancer.gov/Consortia/) recently discovered potential familial 
lung cancer gene (Bailey-Wilson, Amos et al. 2004). Although many lung tumors 
are the result of environmental exposure (smoking), adenocarcinoma of the lung 
most commonly occurs in non-smokers and suggests a familial link.  The study 
identified regions on chromosome 6 showing alterations in a significant number 
of first degree family members with lung tumors, and less significant alterations 
on chromosomes 12, 14, and 20. These are considered milestones in the 
oncogenesis of lung cancer and do not represent a single hit cause of the 
disease. 
Recently, Drs. Bonchev and Kuznetsov (Kuznetsov, Thomas et al. 2008) 
developed a unique method to identify early detection biomarkers in 
Adenocarcinoma of the Lung. In this study Kuznetsov et al. identified a 5 gene 
biomarker that could be used to classify lung cancer using mRNA expression. 
The 5 gene marker set was revealed to represent cross-talk of 25 biomolecular 
pathways in lung cancer. Based on the network analysis, these 25 pathways 
have significant influence on the state of disease and control of cell growth and 
apoptosis. This type of study is a good representation of amount of biomarker 
research done in the lung cancer field. Based in the significant genetic and 
proteomic research done on lung cancer, it represents a good model for this 
study. 
Autism Spectrum Disorders (ASD), which include Autism, Asperger’s Disorder, 
and Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS), are 
severe, extensive neurodevelopmental diseases characterized by deficits in 
social and emotional interactions and communication, as well as the presence of 
stereotypic behavior and restricted interests. Recently, the Centers for Disease 
Control along with Health Resources and Services Administration (HRSA) 
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reported that one in 100 children is affected with an ASD, and declared the 
condition “an urgent public health issue” [United States Centers for Disease 
Control, 2009(2007)]. Clinicians are now faced with a large population of children 
and teenagers with ASD who require accurate and comprehensive assessment 
and effective treatments. Understanding the biological underpinnings, including 
genetic characterization, of this group of disorders will directly impact diagnosis 
and treatment development. In addition, costs associated with healthcare and 
with special education of children with autism are enormous and have far ranging 
consequences on society. 
Twin and epidemiological studies have shown that ASD is the most frequently 
inherited psychiatric disease. Understanding the biological factors that influence 
the course and outcome of ASD is complicated by clinical heterogeneity in this 
group of disorders, by multiple gene etiologies that predispose an individual to 
the disease and by the innate complexity of dynamic gene/protein interactions. 
Identification of cellular protein biomarkers and gene regulatory pathways 
associated with ASD is essential to assess accurately the clinical prognosis and 
allow for the earliest possible intervention to correct behavioral anomalies 
associated with the disease. However, limited information of protein interaction 
networks and complexes involved in ASD is available.  
Insel and Abrahams both recently noted that understanding affected proteins and 
their associated cellular pathways in ASD and other psychiatric disorders is a 
necessary step that will improve diagnostic tests as well as treatments [(Insel and 
Lehner 2007), (Abrahams and Geschwind 2008)]. Inroads relating to analysis of 
genes involved in this complex phenotype have recently been reported.  
Transcription profiling through the use of cDNA microarrays has permitted 
simultaneous analysis of thousands of genes whose expression is either 
increased or decreased in individuals with ASD [(Purcell, Jeon et al. 2001), 
(Yonan, Palmer et al. 2003), (Baron, Liu et al. 2006), (Baron, Tepper et al. 2006), 
(Hu, Frank et al. 2006), (Walker, Segal et al. 2006), (Nishimura, Martin et al. 
2007), (Gregg, Lit et al. 2008)].   A bioinformatics analysis by Yonan et al. 
(Yonan, Palmer et al. 2003) of autism positional candidate genes using biological 
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databases identified 383 candidate genes predicted by a genomewide genetic 
linkage analysis of families that had two or more members diagnosed with ASD.  
In addition, peripheral blood and lymphoblastoid cell lines from autistic patients 
have been used successfully to identify autism-associated gene changes in 
peripheral cells ((Yonan, Palmer et al. 2003; Baron, Liu et al. 2006; Baron, 
Tepper et al. 2006; Hu, Frank et al. 2006; Walker, Segal et al. 2006; Nishimura, 
Martin et al. 2007).  Hu et al. (Hu, Frank et al. 2006) demonstrated that 
lymphoblastoid cell lines from monozygotic twins discordant for severity of autism 
have differential gene expression patterns as determined by microarray analysis.  
Furthermore, genes with the greatest degree of differential expression were 
those associated with nervous system development, structure and function. 
Many of these same genes mapped to chromosomal regions determined in 
earlier studies to be associated with autism candidate genes. A recent report by 
Gregg et al. (Gregg, Lit et al. 2008) also characterized gene expression 
differences in blood leukocytes of ASD patients using microarrays and found a 
small group of genes expressed predominately in natural killer cells, among 
others. Further, Nishimura et al. (Nishimura, Martin et al. 2007) utilized 
lymphoblastoid cell lines from autism patients and identified 68 genes that were 
dysregulated in common between autism with FMR1-FM and dup(15q). This 
study (Nishimura, Martin et al. 2007) also demonstrated increased expression of 
FMR1 interacting protein 1 (CYFIP1) in dup(15q) individuals, which suggests a 
putative link between FMR1-FM and dup(15q). 
Recently, Wall et al. (2009)(Wall, Esteban et al. 2009) compared gene networks 
associated with autism to those of 432 additional neurological diseases with the 
intent of defining shared molecular mechanisms and identifying new genes that 
were important in autism.  Sixty-six candidate autism genes were linked to one 
other disorder—these were referred to as multi-disorder gene set (MDAG). Gene 
networks and protein interactions with all MDAG genes were then defined, which 
extended the potential autism-specific genes to 334 candidates. Of these 334 
genes, 154 genes had not previously been linked to autism, but were 
differentially expressed in autistic individuals. The authors concluded that at least 
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a fraction of these genes may act as “sub-components” of the autism gene 
network and will provide insights into current gaps of our knowledge of this 
disease. Along this line, Purcell et al. (Purcell, Jeon et al. 2001) used microarrays 
to study gene expression on post-mortem brain tissue from individuals with 
autism and matched controls without any symptoms of autism. The study 
demonstrated differential regulation of 30 genes in individuals with autism 
compared to matched controls. Overall, these results affirmed that autism results 
from the dysregulation of multiple genes, which is predicted to have a profound 
effect on brain development.   Taken together, understanding the biological 
underpinnings, including genetic characterization and functional pathways, of this 
group of disorders will directly impact diagnosis and treatment development.  
Innovation 
This proposal is innovative because it proposes a new method to 
determine functional groups in signaling and protein interaction networks. The 
new method combines network topology analysis using existing methods and 
equations with simulation for the purpose of classifying each node in the network 
as master or slave. Existing network analysis tools provide an ideal way to 
classify the nodes in a network as central or peripheral (eccentric). These 
analyses make this classification based entirely on the structure of network, 
assuming there are no edge weights.  This method is ideal for networks of 
computers where each node shares basic characteristics.  This method is also 
ideal for early analysis of biological networks (signaling and protein interaction) to 
determine what nodes are central assuming each node share based 
characteristics.  The shortcoming of this method is that in biological networks 
each node does not always share basic characteristics.  An example of this is 
demonstrated by the diversity of protein structure and functionality found in most 
protein interaction networks.  This proposal addresses this shortcoming by 
combining the metrics described above with cellular automata simulation to 
provide an additional classification of master and slave. The master/slave 
relationship in the network topology might be considered by analogy with central 
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and peripheral nodes, but provides an additional level of information where there 
are multiple redundant pathways sharing the same or similar function.  
Additionally, simulation combined with existing topology metrics being used to 
describe the functionality of ASD progression networks has never been done and 
is badly needed.   
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Chapter 2: Network Construction 
 
Summary:  
This chapter is about construction of a network of cellular gene/protein 
agents and potential molecular regulatory pathways specific for apoptosis 
including the integrated Bcl2 family of genes and proteins from 
interactions reported in BioGRID, Cancer Cell Map, Human Protein 
Reference Database, IntAct, MINT, NCI/Nature Pathway Interaction and 
Reactome databases. Searching and extracting interaction data from 
databases represent the most common way of constructing biomolecular 
networks. This chapter describes the individual methods and techniques 
used to construct and maintain each of these databases. 
 
The current standard for creating visual representations of interacting 
molecules is to search curated databases of interacting molecules derived from 
peer-reviewed publications. The process of populating these databases is called 
“natural language searching”, a technology popularized with the rise of the 
Internet.  Natural language searching includes two major processes: 1. 
Identifying and extracting interaction data from peer-reviewed publications and 2. 
Indexing based on an existing Molecular Interaction ontology of the Proteomics 
Standards Initiative (PSI-MI) (Montecchi-Palazzi, Kerrien et al. 2009).  The 
resulting record represents a binary interaction with supporting data (experiment 
type and reference id).  A third party technology (i.e. Cytoscape) can then search 
these binary records and create n-ary interaction map describing linkages 
between binary records that produce biological interaction/signaling pathways. 
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Biomolecular Databases: 
 Biomolecular interaction databases store data submitted by 
experimentalists and extracted from peer-reviewed publications. The data 
extraction process is sometimes automated using optical character recognition 
software with a list of key words that describe interactions. When not automated, 
the extraction process is done manually. Subject matter experts (SME) read 
publications that describe biomolecular interactions. When enough evidence is 
described in the publications the SME will enter the interaction into the database 
they are curating for. Over time updated versions of the databases are released 
to the scientific community. Table 1 describes the data-capture technique and 
update schedule for each of the databases used for this work.  
 
Table 1 – Survey of publicly available sources of biomolecular interactions used in 
network analsis. 
Database Name Data 
Collection 
Method 
Update 
Schedule 
References 
BioGrid 
thebiogrid.org 
Manually 
Populated and 
Curated 
Monthly (Stark, 
Breitkreutz et al.) 
ChEMBL 
Ebi.ac.uk/chembl/ 
Automated Periodic 
(unscheduled) 
(Overington 
2009) 
DIP 
Dip-doe-mbi.ucla.edu 
Manually 
Populated and 
Curated 
Periodic 
(unscheduled) 
(Sprinzak, Cokus 
et al. 2009) 
INTACT 
Ebi.ac.uk/intact/ 
Manually 
Populated and 
Curated 
Weekly (Aranda, 
Achuthan et al.) 
IReflIndex 
Irefindex.uio.no 
Manually and 
Automated 
(Meta-DB) 
Continuous (Razick, 
Magklaras et al. 
2008) 
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MatrixDB 
Matrixdb.idcp.fr 
Manually and 
Automated 
(Meta-DB) 
Six Months (Chautard, Ballut 
et al. 2009) 
MINT 
Mint.bio.uniroma2.id/mint/ 
Manually 
Populated and 
Curated 
Yearly (Ceol, Chatr 
Aryamontri et al.) 
MPIDB 
Jcvi.org/mpidb/ 
Manually 
Populated and 
Curated 
Yearly (Goll, Rajagopala 
et al. 2008) 
Reactome 
Reactome.org 
Manually 
Populated and 
Curated 
Continuous (Croft, O'Kelly et 
al.) 
 
Construction of Networks 
Using the newly released Cytocape version 2.7.0, an interaction database 
search was conducted using the PSICQUIC Universal Web Service Client. 
PSCICQUIC is a Google sponsored implementation of the PSI-MI that provides 
programmatically accessible molecular interaction data through a standardized 
web service. The database schema, XML and web service client was to be 
installed locally at VCU to allow unpublished interaction data to be integrated into 
the database that was to be created by mRNA data. This became unnessary and 
will be described in a later section. PSICQUIC provides access to BioGrid, 
ChEMBL, DIP, IntAct, IReflIndex, MatrixDB, MINT, MPIDB and Reactome 
databases.  To identify records important for this study the keyword apoptosis 
was used.  As of writing this dissertation, a keyword search of PSCICQUIC 
produced 15396 records. The search tool produced individual networks from 
each of the data sources which were merged, and their overlap used as a basic 
network. A cursory analysis of the search terms was done to evaluate the validity 
of a semantic based analysis. Figure 2 describes the bases of this analysis 
where terms representing key experimental methods represent overlaps that can 
be used to improve the validity of a biomolecular network. 
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Figure 2 – Venn diagram of PSI-MI Tags from Apoptosis Network (PSI standard 
introduced by HUPO) 
 
IntAct is a database of interactions between bio-molecules ranging from 
large protein complexes to small ligands and synthesized molecules. The search 
included one term, Apoptosis, and produced a network of 6393 nodes and 14614 
interactions (as defined by PSI Molecular Interaction standard) (Figure 3 The 
nodes included 31 small molecules, 14 genbank sequences, 21 ensemble 
entities, 3 genbank nucleolus entities, 90 genbank proteins, 70 unique IntAct 
entities, 11 UniParc protein sequences, 6144 UniProt proteins.  The network was 
not completely connected, but included 169 components where the largest 
connected network had 5724 nodes. The second largest network component had 
43 nodes.   
 
Figure 1: Diagram of “Functional Modules” 
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Figure 3 - Largest apoptosis subnetwork from PSICQUIC search of apoptosis associated 
biomolecules. 
Search results from PSICQUIC connected databases (Figure 3) were 
studied for biological validity by analyzing the PSI-MI tags using Starlight 
Information Visualization System created by Pacific Northwest National 
Laboratory (http://www.eurekalert.org/features/doe/2002-03/dnnl-ias061402.php). 
PSI-MI tags describe the types of experiments that produced the interactions 
described in the above databases. Table 3 shows PSI-MI tags from the 
Apoptosis network. These terms are associated with different experimental 
protocols that share common methods. Starlight extracted the common methods 
from the PSI-MI tags and creates diagrams of overlap as seen in Figure 2. This 
analysis identified records that use unproven protocols which can be excluded, 
producing a higher confidence network.  
Search results from Cytoscape were extracted in XML format (XGMML). This 
format included all data provided with the interaction record (source, 
experimental type, publication reference, etc. This XML was imported into 
Starlight’s VIS system using the import wizard. Within the XML schema, edge 
attributes and their associated values were exported and visualized. Starlight 
identified 87,982 words, 219 of which were unique. Starlight was able to cluster 
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these words into 17 groups that were visually filtered into 10 groups (Table 2) 
that included words that described experimental techniques. 
Table 2 – Occurrence of words describing the biological evidence of each interaction in 
the apoptosis network. 
Keyword/s Occurrence in Edge Evidence 
Physical, Association 9011 
Bait, coimmunoprecipitation, anti 3387 
Hybrid, approach, pooling 3123 
Array, assay, microscopy, 
technology, peptide, 
chromatography, protein 
2123 
Tag, coimmunoprecipitation, anti 1543 
Pull 1534 
Purification, tandem, affinity 1524 
Interaction, direct 735 
Reaction, phosphorylation 231 
Chrystallography, x-ray, stelzl 159 
 
Starlight has the ability to visually depict the clusters in three dimensions (Figure 
4). The three dimensions were: occurrence, number of shared XML records, and 
distance between records. 
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Figure 4 - 3D clustering of key terms from PSICQUIC search using starlight visualization 
tool. 
  
Semantic modeling of data is becoming a more popular method of filtering 
search results from web search tools (Nelson, Avraham et al.). Semantic 
modeling is the bases for Starlight VIS, but represents only one type of analysis. 
To verify the results a word map was generated of the same terms used in 
Starlight.  
 In a word cloud the font size is determined by the occurrence of the word 
in the source data (Kaser 2007). The algorithm for determining font size is: 
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Figure 5 - Word cloud representation of interaction data from PSICQUIC search of 
apoptosis. This search was compared with the Starlight search to identify which 
experimental methods could be excluded to increase the quality of the apoptosis network. 
 
Although the word cloud represents a different analysis of using semantic 
grouping, the outcome is similar. From the analysis done in Starlight, combined 
with the word cloud analysis, a more accurate network was prepared (Figure 6). 
The number of protein coding genes is estimated to be around 23,000 
(Stein 2004). This could yield 50,000 to 100,000 thousand proteins in human 
cells. 6400 proteins would represent between 6 and 13% of the entire proteome. 
It is possible that apoptosis includes a high percentage of the proteome, it is 
more likely this network includes inaccuracies. To remove some of these 
inaccuracies, the PSI-MI codes for the experiments for each interaction were 
verified above.  76 Uniquely coded experiments were used to create the 
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Apoptosis network of 5714 nodes. 12 of the 76 were not associated with a 
protocol or were associated with a poorly represented protocol. Removing the 
records associated with these 12 missing protocols produced a network of 3414 
nodes with 5890 edges (Figure 6).  
 
Table 3 – PSI-MI returned during the PSICQUIC search for interactions associated with 
apoptosis. 
ID Term (Type of experiment used to verify interaction) 
MI:004 chromatography: affinity chromatography technologies 
MI:006 anti bait coip: anti bait coimmunoprecipitation 
MI:007 anti tag coip: anti tag coimmunoprecipitation 
MI:0010 beta galactosidase: beta galactosidase complementation 
MI:0012 bret: bioluminescence resonance energy transfer 
MI:0013 Biophysical 
MI:0016 cd: circular dichroism 
MI:0017 fluorescence spectr: classical fluorescence spectroscopy 
MI:0018 two hybrid 
MI:0019 coip: coimmunoprecipitation 
MI:0027 Cosedimentation 
MI:0028 solution sedimentati: cosedimentation in solution 
MI:0029 density sedimentatio: cosedimentation through density gradients 
MI:0030 cross-link: cross-linking studies 
MI:0031 protein crosslinking: protein cross-linking with a bifunctional reagent 
MI:0040 electron microscopy 
MI:0045 Experimental 
MI:0047 far western blotting 
MI:0049 filter binding 
MI:0051 fluorescence: fluorescence technologies 
MI:0053 fps: fluorescence polarization spectroscopy 
MI:0054 facs: fluorescence-activated cell sorting 
MI:0055 fret: fluorescent resonance energy transfer 
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MI:0065 itc: isothermal titration calorimetry 
MI:0067 light scattering 
MI:0071 molecular sieving 
MI:0077 nmr: nuclear magnetic resonance 
MI:0081 peptide array 
MI:0084 phage display 
MI:0089 protein array 
MI:0091 Not Found 
MI:0096 pull down 
MI:0099 spa: scintillation proximity assay 
MI:0107 spr: surface plasmon resonance 
MI:0111 dhfr reconstruction: dihydrofolate reductase reconstruction 
MI:0112 ub reconstruction: ubiquitin reconstruction 
MI:0114 x-ray: x-ray crystallography 
MI:0115 yeast display 
MI:0231 Not Found 
MI:0276 Not Found 
MI:0363 Not Found 
MI:0364 Not Found 
MI:0397 two hybrid array 
MI:0398 two hybrid pooling: two hybrid pooling approach 
MI:0399 2h fragment pooling: two hybrid fragment pooling approach 
MI:0401 Biochemical 
MI:0402 ch-ip:chromatin immunoprecipitation assays 
MI:0404 comigration in gel: comigration in non denaturing gel electrophoresis 
MI:0405 competition binding 
MI:0406 deacetylase assay 
MI:0411 elisa: enzyme-linked immunosorbent assay 
MI:0412 emsa supershift: electrophoretic mobility supershift assay 
MI:0413 emsa: electrophoretic mobility shift assay 
MI:0415 enzymatic studies 
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MI:0416 fluorescence imaging: fluorescence microscopy 
MI:0417 Footprinting 
MI:0419 gtpase assay 
MI:0423 in-gel kinase assay: in-gel kinase assay 
MI:0424 protein kinase assay 
MI:0426 light microscopy 
MI:0428 imaging techniques 
MI:0423 one hybrid 
MI:0434 phosphatase assay 
MI:0435 protease assay 
MI:0440 saturation binding 
MI:0510 Htrf 
MI:0515 methyltransferase as: methyltransferase assay 
MI:0663 Not Found 
MI:0676 Not Found 
MI:0678 Not Found 
MI:0728 Not Found 
MI:0729 Not Found 
MI:0826 Not Found 
MI:0841 Not Found 
MI:0921 Not Found 
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Figure 6 – Visual representation of the optimized apoptosis network produced using 
PSICQUIC enabled tools. 
 
 
Analysis of Optimized Network 
In order to predict the potential modules the largest network was analyzed 
for centroid and degree. Centroid is calculated by focusing on two nodes (w,v) 
and calculating the number of nodes that are closer to each of the nodes (w), 
compared to the other node in the pair(v) (Scardoni, Petterlini et al. 2009). This 
evaluation is then repeated exhaustively for an entire network.  This produces a 
centrality value where the higher the centroid index, the closer the node is to all 
other nodes in the network. Degree is the total number of interactions of each 
node. 
To estimate the functional modules described in this document (Figure 1), 
I calculated the centroid score and node degree for the largest connected 
network of the Apoptosis network described above. Node degree provided a 
general understanding of the connectedness of the entire network of 5724 nodes.  
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Figure 7 shows the range of degrees or connections of the over 5724 nodes. The 
range of degrees spans 378 to one, with one representing the most common 
degree (A biomolecule with degree 378 is unrealistic and demonstrates the need 
to improve the “biological validity” of the data).The protein with the highest 
degree is Q9Y4K3 or E3 ubiquitin lygase, critical for Map Kinase activity. The 
majority are terminal nodes with one connection that may connect to other 
networks not included in the search, or final products. Only 20 of the 5724 nodes 
had a degree of over 100, and without the centroid score most could not be 
interpreted as central. In Figure 8 the centroid score is combined with node 
degree to provide a clearer picture of centrality and control of the network. 
Several of the proteins with high degrees have relatively low centroid values. 
P25694 had a relatively high degree of 126, but a very low centroid score of -
5281. This protein is responsible for scaffold deconstruction, a function that is not 
involved in apoptosis activation.  P35438 also had a high degree and a low 
centroid score. The protein is key to magnesium sensitivity and little to do with 
initiating apoptosis. Both of these proteins represent the limitation of using node 
degree to determine key proteins in functional specific networks.  Although 
centroid provides a good measure of centrality, it cannot identify modules. The 
average centroid score is -5444, but the end of the second largest quartile is -
5480.  The heavy distribution of low scoring nodes demonstrated the low 
sensitivity of the centroid score for functional modules, even when the module is 
central to the network. 
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Figure 7 - Log Distribution Histograms of Node Degrees from Apoptosis Network (Top is from the 
complete network resulting from the search, bottom is the optimized network with unknowns and 
low scoring biological evidence removed) 
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Figure 8 - 3D Log Plot of Centroid Value by Node Degree by Occurrence number in Apoptosis 
Network. (Top is from the complete network resulting from the search, bottom is the optimized 
network with unknowns and low scoring biological evidence removed) 
 
 
Functional modules of signaling networks with related outcomes have a 
common structure of a “master” component that is highly connected and 
activates a series of redundant effected components, which competitively inhibit 
each other but lead to similar outcomes.  This property of the “master” 
component, or “Regulating Promoter” in Figure 1, will be centrally placed within 
the network. To determine whether existing centrality algorithms could predict 
these modules I searched the IntAct database for all records associated with 
Apoptosis and performed a centrality analysis using degree and centroid score.  
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Chapter 3: Network Simulation of Bcl2 Family Proteins 
 
Summary:   
Bcl2 is a family of proteins responsible for apoptosis and cell cycle 
pathways related to apoptosis. Bcl2 represents an ideal model of network 
motifs that control large cellular functions. To identify motifs represented 
in the Bcl2 family pathways I simulated Bcl2 family protein networks to 
using cellular automata driven agent-based modeling. The outcome was 
list of potential motifs that fit the behavior described in my hypothesis and 
a deeper understanding of why this these motifs demonstrate very complex 
behavior. 
   
Cellular Automata analysis 
Cellular Automata was introduced by John von Neumann and Stanislaw 
Ulam in the 1960’s (Kier, Seybold et al. 2010). Von Neumann proposed two-
dimensional CA systems represented on a grid could change states following 
rules derived from the state of the neighboring cells (Neumann and Burks 1966). 
Von Neumann’s early CA systems allowed for up-to 29 different states and 
provided limitless potential outcomes which made them become cumbersome to 
work with. In the early 1980’s, Stephen Wolfram (Wolfram 1983) developed one-
dimensional CA systems where the state of a cell was determined from the state 
of the cells during the previous iteration of the simulation. As iterations continued, 
one-dimensional CA’s produced a finite number of outcomes. Rules based on 
these outcomes have been used to develop a new theory for computational 
analysis (Wolfram 2002). 
 Two-dimensional simulations have been adapted for simulations used in 
molecular interaction and biology (Bonchev, Thomas et al. ; Kier 2008) . In these 
simulations, the grid introduced by von Neumann represented interstitial space, 
and each square was a molecule. The rules von Neumann used to change the 
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state of his cells were modified to closely follow molecular mechanics. 
Simulations resulting from these modified von Neumann systems were shown to 
predict the boiling point and melting point of several compounds, and predict the 
diffusion rate of one mixture through another (Kier, Seybold et al. 2010). 
Following completion of the interaction searches and network topology 
analysis, simulation using two dimensional CA systems was used to predict the 
behavior of the interaction network(Strogatz 2001; Kier, Bonchev et al. 2005). 
The rules were based on the maximal number of interactions for each molecule 
represented in the network coupled with structural analysis of bonding regions 
identified from 3D structures (from the protein databank). Structural analysis 
included evaluation of multiple isoforms, and mutated versions of proteins for 
lipophobicity and electrostatic potential using the Adaptive Poisson-Boltzmann 
Solver with Amber force-fields as described by Baker et al. (Baker, Sept et al. 
2001). These properties were mapped, color-coded and visualized for evaluation 
using PyMOL. Areas with high lipophobicity and high electrostatic potential were 
considered possible binding sights for the simulation but provided no additional 
rule not already extracted from the literature searches.  
Where graphical representations did not exist, generalizations were 
employed based on biochemical characteristics of the predicted solvent 
accessible surface combined with interaction reported in IntAct. Multiple 
generalizations were based on most probable conformation providing a range of 
bonding properties to be included in simulations were multiple confirmations were 
possible. Simulations were done on a 64 bit multiple node supercomputing 
cluster at the CSBC. CA models representing protein networks were comprised 
of four-sided shapes (cells). The cells were variegated allowing up to 4 unique 
protein-protein interactions per representative protein. Rules of motion were 
based on probability and govern movement, joining and breaking of cells. 
Movement, joining and breaking opportunities will be universal and have equal 
probability. The only variations in behavior resulted from rules of interaction 
defined above. Movement was applied randomly to each cell representing an 
asynchronous model (as seen in natural processes). Types of bonds and 
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complexes were tracked and represented the output of the simulation. Iterations 
begin with a random distribution of cells and executed until a steady state was 
identified (no change in binding for multiple iterations).  
A new set of simulations was conducted where each rule will was 
exhaustively changed and removed and run to reach a new steady state. As 
described below, not all rules needed to be changed to obtain the complete 
behavior of the network.. Many rules represented repetitive or redundant 
functions and only needed to be simulated by a single rule change. Changes or 
loss of steady state was tracked and evaluated for impact on the overall network. 
The results were molecular bonding probabilities (strengths) that separate 
equilibrium states or other simulation behaviors. Gene/protein representations 
that lead to large changes in the simulations were considered potential regulatory 
pathways with a “master” classification. Remaining genes/proteins were ranked 
by predicted impact on simulation behavior with a “slave” classification. 
Completion of these tasks resulted in network motifs that address the validity of 
the hypothesis. 
 
Bcl2 Simulations: 
Two Bcl2 networks were simulated. The first includes four agents {Bcl2, 
Bcl2L10 (BclX), Bax, Cytochrome C (CytC)}. These four agents may represent 
multiple states (activation) and interaction. Four models were created that 
included each of these agents. The variations between the models were based 
on disagreements in the literature about the interaction of BclX with Bcl2. The 
use of diverse but similar models also provided a useful method to identify 
higher-level behaviors that were used to establish methods for analysis.  
 The first model if his network included no interaction between BclX and 
Bcl2 (Figure 9). The model included changes in the states of Bax, Bcl2 and CytC.  
Bax changed states from activated Bax to survival factor (SV), to represent 
inhibition of Bax’s apoptosis promotion properties by BclX (Hoffmann and 
Valencia 2004). Bcl2  changed states from activated Bcl2 to deactivated Bcl2. 
This represents the inhibition of Bcl2’s apoptosis inhibition properties by Bax 
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.CytC changed state from inactive to active CytC (AcytC), associated with the 
release of cytochrome C from pores in the mitochondria promoted by Bax. CytC 
also changed to SV to represent direct inhibition of the release of cytochrome C 
from the mitochondrial pores by BclX and Bcl2  . This network represents five 
separate pathways. The second model (Figure 10) includes each of the 
interactions represented in Figure 9 but adds one change state. Bcl2 changed to 
Bc2 homodimer (B2B2) to represent homodimeriation reported in the literature 
(Figure 10)(Zhang, Szustakowski et al. 2009). The third model included each of 
the interactions represented in the first model (Figure 9), but added two changed 
states (Figure 11). Bcl2 changed to Bcl2 bonded to BclX (B2BX). BclX changed 
to B2BX. Each of these interactions had been reported in the literature (Cheng, 
Wei et al. 2001; Jourdan, Reme et al. 2009). The fourth model combined each of 
the previous three to create a more complete interaction map (Figure 12). This 
model includes eight individual pathways with seven changed states. 
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Figure 9 – First model of the Bcl-2 network used in cellular automata simulation of proteins 
associated with apoptosis. 
Figure 10 – Second model of the Bcl-2 network used in cellular automata simulation of proteins 
associated with apoptosis. This model expanded on the second model by including the Bcl-2 
homodimer reported in co-immunoprecipitation studies. 
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Figure 11 – The third model: A different version of the second Bcl-2 model where the Bcl-2 
homodimer was replaced with a Bcl-2, Bcl-X heterodimer. 
Figure 12 – The third Bcl-2 model used in cellular automata simulation. This model combined the 
two versions of the second model where Bcl-2 can produce a homodimer, and a heterodimer with 
Bcl-X 
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 When simulated using CA the results of the first model showed 
convergence of the SV (representing survival) and AcytC (representing 
apoptosis) concentrations between the bonding probabilities of 0.5 to 0.6 of BclX 
interacting with Bax (inhibition of Bax). This result was used to identify other 
convergence points in the other three models. New convergence points only 
emerged in the third (Figure 11) and fourth (Figure 12) models. The new 
convergence points in model three occurred from the interaction between BclX 
and B2BX at probabilities 0.01 to 0.02 and 0.07 to 0.08. In the fourth model 
convergence points emerged at the interactions of BclX and CytC at probabilities 
of 0.72 to 0.7; the interaction between BclX and Bax at probabilities of 0.42 to 
0.4; and the interaction between BclX and B2BX at probabilities of 0.015 to 0.01. 
The resulting narrow ranges of existence of the survival state demonstrate the 
significant challenges for drug discovery and clinical treatment of lung cancer. 
 
 The Bcl2 family-related apoptotic pathway is highly redundant of pro-
survival and pro-apoptotic proteins, which provides a unique network for 
modeling and simulation. The second Bcl2 network analyzed here was designed 
to uncover the impact of this redundancy on the Bcl2 protein, which has limited 
spatial accessibility. The model included the pro-survival proteins Bcl2 and BclX 
(Bcl2L1) and the pro-apoptotic BID and BIM (Bcl2L11) (Xue, Chiu et al. 2003; 
Kerrien, Alam-Faruque et al. 2007; Jourdan, Reme et al. 2009; Renouf, Wood-
Baker et al. 2009). We modeled the limited Bcl2 accessibility by altering the 
dissociation constant from 1 to 0. Also included were non-Bcl2 proteins that were 
reported to bind to Bcl2 family proteins in tumor formation. All interactions 
included in the model had been reported in the IntAct database (Kerrien, Alam-
Faruque et al. 2007) to be related to cancer or apoptosis. The completed model 
included 11 proteins with a total of 14 interactions (Figure 13). Two of the 11 
proteins were isoforms of included proteins that were reported in different 
pathways from the wild-type. To simulate the model each protein was 
represented in a CA simulation by a single variegated cell. A variegated cell has 
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more than one rule of behavior for each of its sides. The CA engine determines 
whether a variegated cell can bind by evaluating the rule of the specific side of 
the square cell that is neighboring another cell. In the case where a protein has 
one binding side the variegated cell would have two rules, one binding and three 
non-binding. The single binding side would be able to bind other proteins and the 
three non-binding sides would not be able to bind with any other protein. The 
ability to bind was determined by normalized probabilities (the sum of each cell’s 
binding probabilities, describing interactions with other cells, cannot exceed one). 
Of 14 interactions, four had published dissociation constants that were used as 
breaking probabilities between two cells in the CA simulation. Where no 
disassociation constant was reported, a breaking probability of zero was entered. 
Each summation was run for approximately 10,000 iterations to reach a steady 
state, and repeated 50 times.  
 
Figure 13 – This expanded Bcl-2 network included interacting partners that were not known to be 
Bcl-2 family members, but were similar in structure and had been reported as interacting partners 
with known Bcl-2 family proteins. 
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The CA input files included, among others, the list of all pairwise interactions and 
their probabilities (Table 4). 
Table 4 – List of interacting partners include in the expanded Bcl-2 network (Figure 13) 
Bcl2  Bcl2 
Bcl2  BclX:iso 
Bcl2  NLRP1 
Bcl2  BIM 
Bcl2  PPP1CA 
Bcl2  BIM:iso 
Bcl2  BID 
BclX  BID 
BclX  NLRP1 
BclX  PPP1CA 
BclX  BIM 
BclX  HRK 
BclX:iso  SIVA1 
PPP1CA  BAD 
 
The model probabilities were normalized to a unit (Table 5). 
 
Table 5 – List of probabilities created for each pathway found in the expanded Bcl-2 network (Figure 
13) 
BIM:iso-Bcl2 + Bcl2-Bcl2 + BID-Bcl2 + BclX:iso-Bcl2 + NLRP1-Bcl2 + BIM-
Bcl2 + PPPICA-Bcl2  1 
Bcl2-BclX:iso + SIVA1-Bclx:iso  1 
BAD-PPP1CA + BclX-PPP1CA + Bcl2-PPP1CA  1 
HRK-BclX + BID-BclX + NLRP1-BclX + BIM-BclX + PPP1CA-BclX  1 
BID-Bcl2 + BID-BclX  1 
BIM-Bcl2 + BIM-BclX  1 
NLRP1-Bcl2 + NLRP1-BclX  1: 
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Bcl2 had a dissociation constant of one, which was included in the control 
simulation. Three other simulations were then run representing the absence of 
the redundant BIM path (see Figure 13), the loss of Bcl2’s ability to dissociate 
and the combination of the two. The terminal path including the BIM isoform was 
monitored to evaluate the result of the changes. The loss of Bcl2’s ability to 
dissociate from its binding partners and the loss of BIM resulted in a 20% 
reduction of the BIM isoform complex. This is believed to be the result of 
sequestered free Bcl2. 
One may conclude that the highly redundant Bcl2 protein family network 
provides an ideal model for studying the effects of damaged redundant network 
paths in cancer, yielding alternative therapeutic approaches. The early results of 
this simulation provided a link to the effects of a lost redundant path to the 
sequestering of free Bcl2. We predict that the effects of a lost path, as a result of 
carcinogenesis, could be overcome by altering the dissociation of Bcl2.  
 
Resulting Motifs 
 In addition to the analysis of the importance of concentration in the Bcl2 
family network previously described, two motifs were identified in the second 
Bcl2 network (Figure 14). More network motifs would exist if the Bcl2 network 
was analyzed in context of the larger apoptosis network, discussed in the next 
chapter. The first identified network motif was a three-node two-edge directed 
one (Figure 15), representing a basic signaling cascade. This motif occurred 40 
times with a ratio of 1.05 (ratio = (observed in network)/(mean occurrence in 
random networks)) with a p-value < 0.01.  
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Figure 14 – 3-Node, 2 Edge Linear Motif 
 
 
Figure 15 – 4-Node 4-Edge Biparallel Motif 
The second motif of four nodes and four edges occurred twice with a ratio of 2 
and p-value <0.01. Further analysis of these motifs and the three additional 
networks that were dependent on the rest of the apoptosis network are discussed 
in the next chapter. 
 
  
35 
 
 
 
 
 
 
Chapter 4: Differential Analysis 
 
Summary: 
Recently, new methods to develop de novo networks from patient data 
have been developed. To identify a differential network of cellular 
gene/protein agents and potential gene regulatory pathways specific for 
functional changes associated with apoptosis I compared these methods 
to earlier described database searching methods. Although these methods 
are useful in evaluating networks associated with well understood 
functions in small populations, they can produce overly specific networks. 
For this reason the motif analysis only included networks from the 
databases described earlier. 
  
Analysis of Microarray Data from Lung Cancer Patients 
mRNA microarray expression data from individuals diagnosed with 
Adenocarcima of the lung were obtained from the Oncomine database, the NCBI 
GEO database and EBI’s ArrayExpress database. Experiments that share 
platforms, methods and patient characteristics including mRNA from adjacent 
tissue were merged to provide a dataset of interaction data from at least 200 
patients with adenocarcinoma of the lung. 
The first steps of the Network Builder algorithm involves extracting random 
directional vectors for each gene in Gene Ontology (GO) lists (Ashburner, Ball et 
al. 2000; Bard 2003). As stated in the Introduction, correlation-based methods 
show the most promise while maintaining the complex systems properties of 
biological networks. Current tools that offer “de-novo” network creation only 
calculate a pair-wise correlation. The tool used in this analysis correlated groups 
of probes represented by vectors. Network Builder, the tool used in this study, 
integrates a unique 2-D clustering with maximization of non-linear correlations 
that maintains dynamic behavior when creating a de-novo network from 
36 
 
 
 
 
experimental data. Recent studies by Zhang et al. (Zhang, Ji et al. 2007) have 
described the strength of multi-gene correlation analysis compared to pair-wise. 
This tool expanded on Zhang’s work by moving beyond three gene interactions. 
This study utilized expression vectors representing 3 to 50 interactions, which are 
evaluated using a combined clustering and correlation algorithm.  The algorithm 
aligned each vector individually on a two-dimensional grid. Clusters were 
identified using GAP statistic. Each pair of two genes that presents more than 
one significant cluster was recorded as having a potential interaction. The 
algorithm then organized networks for the entire pool of 1000 genes. Sub-
networks were created based on first neighbors for each gene starting with the 
gene represented with the highest node degree (potential interactions). Random 
vectors were extracted from each partition and non-linear correlation coefficients 
(Rho) was calculated between groups of vectors from genes in a sub-network 
between lung tumor samples and adjacent normal tissue. This value represented 
a random base correlation. In contrast, partial regression uses a linear-based 
reduction method that cannot account for compounding dynamic behaviors 
commonly seen in networks.   
New vectors were extracted from each partition after the data was 
redistributed based on clinical features (i.e., stage of tumor, age, etc) that are 
believed to vary in the patient pool. Spearman Rank Correlation Coefficient (Rho) 
was derived for each sub-network with each directional clinical-based 
distribution. Spearman correlation produces a coefficient between -1 and 1, 
where as the distance from 0 (on a number line) increases, the statistical 
dependence between two vectors increases. Clinical distributions with the largest 
rho (exceeding random base correlation) derived from these groups of vectors 
was selected and used in the following analysis representing directional base 
correlation. Sub-networks were reduced gene by gene with new values for rho 
calculated and comparisons done between patients with varying clinical 
characteristics.   
When rho for each group of directional vectors reached statistical significance 
(using distance from 0 and within a small range), subnetworks were then 
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combined to produce an accurate interaction network representing chromatin 
associated pathways.  Ontology terms were the used to partition the merged 
network into a subnetwork of apoptosis pathways associated with 
adenocarcioma of the lung and chromatin. This network will then be tested 
against networks described earlier.  Each network will be studied to identify 
topological limitations, i.e., the network diameter, node and edge degree as 
reported (Milo, Shen-Orr et al. 2002; Dorogovtsev, Goltsev et al. 2003; Rives and 
Galitski 2003).  These values described the maximum number of potential 
interactions.  
Subnetworks were then searched in the resulting network. It was expected 
that subnetworks will match and rho values will be evaluated to see whether they 
indicate a new unpublished interaction.  Whenever the rho value was too small, 
the interaction was labeled as a false positive and removed from the sub network 
and a comparison was done.  After this optimization step was complete, ontology 
terms were added to each sub network to see if the sub network represents a 
functional group. The chromatin example below provides an example of this de-
novo network building approach. 
 
Figure 16 – Normalized expression values were plotted after being sorted (low to high) by different clinical 
features. Each color represents a different clinical feature use for sorting the expression values. 
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Chromatin (This work was done in collaboration with Dr. Vladimir Kunetsov 
from the Bioinformatics Institute of Singapore): 
 An initial search of the Gene Ontology DB produced a list of 134 genes 
associated with chromatin (Ashburner, Ball et al. 2000). This list included genes 
that are associated with chromatin accumulation, assembly and remodeling. 
Modeling and simulating the entire group of 134 genes, as described earlier, was 
difficult. An alternative analysis of expression profiles using non-linear correlation 
coefficients and a proprietary clustering algorithm was employed. Expression 
data of 71 patients with adenocarcinoma of the lung compared were to 16 
healthy samples (Rhodes, Kalyana-Sundaram et al. 2007). Expression data was 
captured using an Affymetrix u95a platform. Results of the analysis identified 
pack-years followed by TNM staging as providing the most predictable 
coefficients (Figure 16). This analysis also identified 14 genes as potential core 
genes (Figure 17 – Created by Dr. Danail Bonchev). 
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Figure 17 – This network was produced using Ingenuity Systems IPA network analysis tool. A list of 
proteins/genes was entered into the search tool and this network was produced. The list of 
proteins/genes was produced using the correlation analysis described in the text. 
 
Table 6 - Ontology of chromatin genes identified as potential biological markers using the analysis 
described in the text. These markers could be used to discriminate between diseased and healthy 
tissue. 
 
H2AFV Histone Construct 
SFRS3 Splicing Factor/RNA Process 
RB1 Transcription Regulator 
HistH3 Histone Construct 
CBX6 Transcription Regulator 
HOXA9 Transcription Regulator 
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Hist1H4C Histone Construct 
NXF1 Transporter 
U2AF1 Unknown 
SFRS1 Splicing Factor/RNA Process 
SNRP70 Splicing Regulator/RNA 
CASP11 Splicing Regulator/RNA 
PRPF4B Kinase 
SFRS8 Splicing Factor/RNA Process 
 
We then used additional mRNA expression data for individuals diagnosed 
with adenocarcinoma of the lung from Oncomine (Rhodes, Kalyana-Sundaram et 
al. 2007) and from Genome Expression Omnibus (GEO, 2007) (Barrett, Troup et 
al. 2007). These were two very diverse datasets based on different platforms and 
even patients of different ethnicity, selected as a test for the classification 
reproducibility. The Oncomine U95A platform of expression data (12,600 probes) 
involved a classification study of patients with lung malignancies (Bhattacharjee, 
Richards et al. 2001) including 62 adenoncarcinomas and 17 normal samples. 
The 62 adenocarcinomas were selected based on agreement between 
assessments of two independent pathologists. Samples where one report did not 
indicate pure adenocarcinoma were excluded, and the same was done with the 
data for patients with secondary metastasis of a different morphology. This 
produced a dataset of pure adenocarcinomas with no metastasis, tumor sizes of 
1 to 8 cm, and all stages. The Bhattacharjee et al. expression data 
(Bhattacharjee, Richards et al. 2001) were thus partitioned into five subsets, four 
of which containing 15 or 16 tumor samples each randomly selected from the 
pool of 62 samples, and one set of expression data with 17 normal samples. The 
GEO U133A platform (22,284 probes) contained expression data from 27 
adenocarcinoma patients with accompanying data from adjacent normal tissue 
(Su, Chang et al. 2007). Expression data was thus presented in two sets of 27 
samples each (normal and diseased ones). 
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Our novel strategy limited strongly the starting gene list by focusing on 
certain hypothesis as to which biological processes and molecular functions are 
of importance in carcinogenesis. One can thus identify proteins that are strongly 
affected in the different stages of lung adenocarcinoma. Recent studies on the 
mechanisms of lung cancer pay a considerable attention on the chromatin 
structure changes, and histone as the chief protein component of chromatin 
(Cameron, Bachman et al. 1999; Reisman, Sciarrotta et al. 2003; Sasaki, 
Moriyama et al. 2004; Gibbons 2005; Medina, Carretero et al. 2005). Proteins 
related to DNA modification, MAP Kinases activity, and transcription were also 
considered of importance. This choice enabled the compiling of two lists of 
proteins. The first one with 98 genes was based on Gene Ontology Database 
[GO] (Ashburner, Ball et al. 2000; Bard 2003) classifications provided by 
Affymetrix Inc. The second list with 43 genes was a merge of Panther (Thomas, 
Campbell et al. 2003) and David (Sherman, Huang da et al. 2007) ontology and 
GO terms, of the four categories described above. Thus, our search started with 
a combined list of 141 genes.  
For each of the two gene expression datasets (Su et al. data (U133A)(Su, 
Chang et al. 2007) GEO ID GSE7670; Bhattacharjee data (U95A)(Bhattacharjee, 
Richards et al. 2001),  provided by Oncomine (add reference) we first calculated 
the Spearman non-parametric correlation coefficients ρ between pairs of 
hybridization signals of all probesets of expressed genes presented on a 
microarray for all patients included (complete cohort, normal and diseased). 
Gene expression was defined as the normalized signal for each probeset ID 
associated with a gene, as provided by Affymetrix Corporation. The number of 
probeset IDs per gene ranged from one to eight. The results of the pair-wise 
analyses did not provide clear results, due to large groups of predicted 
interactions with the same correlation coefficients. In addition, the correlation 
values were significant but not highly correlated. This result agrees with the 
recent conclusions of Zhang et al. (Zhang, Ji et al. 2007) that pair-wise 
correlation could be “a poor predictor of any molecular interaction associated with 
signaling and control of cellular function”. Instead, Zhang used correlation 
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between triples of genes. In this study, we applied a more sophisticated 
correlation analysis which extends the correlation to larger groups of 3 to 100 
genes and includes a clustering step (Thomas 2008). We employed two-
dimensional clustering using the so-called gap statistic to define a cluster of 
probesets. No pre-filtering procedure was used for removing noise signals and 
outlier patients. A cluster is defined as a group of expression signals where the 
number of members is greater than one, and the expression values used for 
input are from two different probesets representing two different genes (for 
example, a cluster including expression signals for probeset A and probeset  B 
with a cohort of 20 samples would consist of 40 unpaired expression signals). 
The Gap statistics uses the output of traditional clustering algorithms but 
determines the difference between an internal dispersion of the variables within 
the predicted cluster and a null distribution. The distance between two 
nonnormalized expression signals was determined as Euclidean distance. The 
two dimensional aspect of our clustering approach refers to the bivariate plot 
graph in which the clustering is determined. The graph x coordinate stands for 
the values for all expression signals for probeset of gene A across all samples, 
while y is the same for a probeset of gene B across the same samples. So, if an 
individual sample is denoted by k, the point on the graph representing that 
sample is denoted as kxy and the number of such points equals the total number 
of samples. Distance is then determined between each kxy and kx’y’ and 
compared to the null distribution created by the Gap Statistics. If the sum of 
distances within the entire subset is less than that in the null distribution, the 
subset is reported as a cluster, as defined above. If the clustering of two 
expression signals (probes A and B) produced two or more clusters, then an 
interaction between the genes presented by the two expression signals from the 
probes was recorded as a predicted interaction. Since this clustering step was 
done exhaustively, each gene in the gene lists had several other genes identified 
as potential interactions. The Spearman correlation coefficient ρ was then 
determined for each list of potential interactions. All lists of each probeset 
represented the hybridization signal of transcripts on microarray were then 
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combined and the number of predicted interactions for each probesets was 
counted. The count was used as a predicted node degree in a network 
representation of highly correlating genes, the nodes and edges in which 
represent the genes and their interactions, only correlation coefficients identified 
as significant (p < 0.05) were used.   
Supervised optimization was performed using Spearman’s ρ to compare potential 
interaction lists resulting from clustering. Optimization was considered complete 
when ρ reaches statistical significance (p < 0.001). The optimization process 
included removing the probe with the lowest cluster number, and reevaluating 
correlation. This was repeated for each probeset represented in the potential 
interaction lists. When the correlation coefficient increased, the probeset was 
permanently removed, and vice versa, when the correlation coefficient decreased 
the probeset was returned to the potential interaction list. After completing the 
optimization, network maps were built. Each probeset ID was replaced by a gene 
symbol and when multiple probe IDs existed for a single gene correlation 
coefficients were compared. If correlation coefficients were the same, the 
duplicated probe ID was dropped. If the coefficients were not the same, a study 
of the hybridization was done in the form of a literature search and the less 
reliable probe ID was dropped. This last step was not necessary, due to the 
normalization using Bioconductor (www.bioconductor.org) and similar tools done 
prior to analysis (Zhang, Szustakowski et al. 2009). The count of genes in the 
optimized list represents the final node degree in the network. The analysis of the 
close neighborhood of this network makes possible the prediction of other 
potential markers among the genes that are closely connected to the preliminary 
selected candidate genes.  For all predicted interactions determined by the 
correlation analysis we performed a literature search and Pathways Studio® 
(Nikitin, Egorov et al. 2003) search for information on existing regulatory, binding 
and other interactions or other relationships. This final step was used to verify 
potential biological implications of the constructed networks. Each network was 
also analyzed to identify topological limitations, such as network diameter, node 
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and edge degree, centrality, etc. (Milo, Shen-Orr et al. 2002; Dorogovtsev, 
Goltsev et al. 2003; Rives and Galitski 2003). 
 
Resulting Motifs 
  As a result of the high level specificity of the chromatin analysis I 
determined a that the network resulting from patient data was likely to not have 
enough information to identify important controlling motifs. The network used 
during the analysis was from the reduced, high confidence, PSICQUIC network 
shown in Figure 6. To identify motifs I used the NetMatch Cytoscape Plugin 
produced by the Bader lab at the University of Toronto (Ferro, Giugno et al. 
2007). Five motifs were identified as possible candidates to address the 
hypothesis.    
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Figure 18 – 4-Node, 4-Edge 
Non-Symmetrical Non-Linear 
Motif 
 
Figure 19 – 4-Node, 4-Edge 
Symmetrical Non-Linear Bi-Fan 
Motif 
 
Figure 20 – 4-Node, 4-Edge Bi-
parallel Motif 
 
Figure 21 – 6-Node, 9-Edge Tri-parallel Motif 
 
Figure 22 – 5-Node, 6-Edge Tri-parallel Motif 
 
A selected subgraph is only important and is called “motif” if it occurs at a rate 
different from that in random networks. To test this I generated 1000 random 
networks with the same average node degree, diameter, number of nodes and 
number of edges to compare the frequency of occurrence. Table 8 contains the 
results of this analysis. 
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Table 7 – Results of the motif search using NetMatch plugin with Cytoscape against the apoptosis 
network. All the ratios are low when compared to the mean network counts from all 1000 random 
networks. 
 
Figure 18 19 20 21 22 
Standard 
Deviation 
4004.16 990.74 285.68 1369.7 33,890 
Mean from 
Random Net. 
 
38,217 8561 19,643 4689 36,935 
Count in Network 3954 5732 706 2628 39084 
Standard Error 400 99 9.03 144.37 3572.4 
z-stat -85.57 -28.55 -2096 -14.27 0.587 
p-value <0.01% <0.01% <0.01% <0.01% 27.8% 
Ratio 0.103 0.669 0.036 0.560 N/A 
 
 FANMOD (Wernicke and Rasche 2006) is another tool commonly used for 
the identification and analysis of motifs in networks. FANMOD has strict 
formatting requirements that limit ability of this tool to read biomolecular networks 
generated from database searches (described earlier). The FANMOD input file 
must include only integers, representing vertices, and have one edge per row. 
Additionally the software can only read windows encoded Unicode 8-bit text files, 
even when the program is installed on a Linux or Unix machine. Due to these 
limitations, I was only able to analyze the autism network described in Chapter 5. 
The methods used to convert the network to be analyzed in FANMOD and the 
results are described in that chapter.  
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Chapter 5: Autism Networks 
 
Summary: 
To identify whether the motifs found in apoptosis were limited to 
only networks that are well studies I created a network of interactions 
reported in Autism Spectrum Disorder (ASD). From this network we 
identified the same motifs as those found in apoptosis, including increased 
significance in the larger motif. Interestingly, in the apoptosis network we 
found motif counts significantly lower than those in random networks, 
while in Autism we found motifs in consistently higher abundance than 
found in random networks. 
   
Analysis of Protein Interaction Networks 
 To generate a protein interaction network associated with apoptosis, I 
used the PSICQUIC search tools built into Cytoscape. This tool was unable to 
identify any interactions associated with Autism. The PSICQUIC tool is designed 
to use an XML based standard that has a limited ontology. As a result the user 
can get a network from a meta-database search with better specificity than 
searching each database individually. This removes the redundancy and reduces 
the false hits. Unfortunately, this also removes the diversity of terms available. 
Since most interactions are associated with cancer, without a cancer related 
term, it is difficult to get a larger representative network from PSICQUIC. 
 NCBI provides an additional search tool built into Cytoscape (Sayers, 
Barrett et al.). This tool allows Cytoscape users to search with the Entrez utility 
across NCBI’s databases. By using this tool, I was able to generate a network of 
biomolecular interactions in Autism with 1621 nodes and 3997 edges (Figure 23). 
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Figure 23 - Autism network produced using the NCBI search tool. This was the only search target 
and tool that was able to produce a network using search terms associated with autism. 
 
 In addition to NetMatch, FANMOD was used to search for and analyze 
motifs in this Autism network. NCBI uses integers as identifiers in networks 
generated by the Entrez tool. FANMOD is sensitive to gaps (missing integers) in 
the set of integers representing nodes, and cannot accept integers larger than 
65,500. The Autism network has 1621 nodes with, integers ranging from 100 to 
37,547,124. To compress the range of integers, I factored the numbers on a log 
scale ranging from 4 to 4000. The result was a set of integers that fit into the 
range of FANMOD. The factoring included a rounding step were factoring did not 
produce an integer. This step did result in the loss of several nodes, which may 
have significant impact on the results. This was made clear by the statistics of 
the Apoptosis network reported by FANMOD (number of nodes = 65107, number 
of edges = 1888). The error in node count is a programming bug where 
FANMOD reports the highest integer as the node count for the network. The loss 
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of half the edges could be a combination of multiple records (edges) for the same 
interaction, and loss resulting from the factoring and rounding of the integers. 
 
Resulting Motifs 
 As described in the previous chapter, 1000 randomized autism networks 
were generated to determine how far the occurrence count of the motifs deviated 
from that of random networks using the NetMatch Cytoscape plugin. The autism 
network included all five motifs (figures 18 - 22) which deviated significantly from 
the average 1000 random networks (Table 9). 
Table 8 - Results of the motif search using NetMatch plugin with Cytoscape against the autism 
network. All the ratios are high when compared to the mean network counts from all 1000 random 
networks. 
 
Figure 18 19 20 21 22 
Standard 
Deviation 
 10,402 696.56  31.87  465.5  399.04  
Mean from 
Random Net. 
 
 15,510  4760  50.24  561  482.5 
Count in Network  25158  9836  272  2412  2412 
Standard Error  1040  73.42  1.01  46.6  39.9 
z-stat  9.27  69.12  220  39.75  48.35 
p-value  <0.01%  <0.01%  <0.01  <0.01  <0.01 
Ratio  1.62  2.07  5.41  4.30  5.00 
 
The results obtained from FANMOD (Table 9) did not include the same 
motifs found using the NetMatch plug-in (Table 8), although, the motifs that were 
found existed in the same high ratios as discovered using NetMatch. 
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Table 9 - Results of the motif search using FANMOD against the autism network. All the ratios are 
high when compared to the mean network counts from all 1000 random networks. 
 
Motif 
    
Standard 
Deviation 
6.38 e-6 2.67 e-6 2.36 e-4 4.43 e-5 
z-score 5.39 4.4594 4.06 3.54 
p-value 0.005 0.004 0.005 > 0.01 
Ratio 9.43 4.67 4.61 2.4 
 
 Of the two tools used to study motifs, NetMatch is likely more reliable 
because it uses the networks in the original formatting without any modification. 
FANMOD is a more robust tool, because it has the ability to exhaustively search 
for motifs of a defined size. Unfortunately, the limited input formats make it less 
reliable for biomolecular networks created using interaction databases, even 
when the resulting network uses integers as identifiers for nodes. Accounting for 
the qualities and limitations of each program, high ratios were exhibited in all 
motifs found in the Autism network. Since it was found using both programs, it is 
difficult to define it as an artifact, but it is more likely a descriptive characteristic of 
the known Autism network, and could be useful in understanding the depth of 
existing knowledge about signaling and regulation associated with Autism. Due 
to the uncertainty associated with the FANMOD results, the following chapter will 
only discuss the NetMatch results. Further analysis with FANMOD should be 
performed for additional validation, but only in combination with a more robust 
input file conversion tool. 
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Chapter 6: Discussion and Future Work 
 
Summary: 
 The data resulting from this study has provided some support for the 
hypothesis that a master slave arrangement shown in a motif represents a 
key functional group of the network. The results between apoptosis and 
autism were inconsistent, but within each disease type they were very 
consistent. This suggests the ratio of occurrence is sensitive to the 
network completeness and could be exploited as a measure for this 
completeness, in addition to providing an indication of the presence of 
functional groups, affected by disease. 
 
Discussion 
The purpose of these studies was to discover if there is an optimized sub-
network (motif) structure that could be used to identify functional groups.  
Optimization, in this context, can have at least two meanings.  If the result of the 
optimized network is to accelerate the flow of information, then the optimized 
sub-network should have a higher frequency in biological networks. If 
acceleration of information flow is a secondary result of the optimization, and the 
primary result is to control the expression of pathways connected to the motif, 
then the sub-network should have a lower frequency in biological networks. I 
expected the second meaning of optimization to include biomolecular signaling 
networks associated with control. Although the design of this study was heavily 
influenced by these definitions, they are not exhaustive and need further 
investigation prior to being considered theory. 
 This study was limited to the optimization associated with pathway control 
seen in the Apoptosis in Lung Cancer network and the Autism network. This is 
because these two networks had the highest confidence, while being significantly 
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diverse and of large enough size.  After normalization by use of the semantic 
analysis of the PSI-MI tags, the Apoptosis network had 3400 nodes representing 
proteins, genes, ligands and small molecules. This network also had 5857 edges. 
Compared to the original network of 5724 nodes and 13810 edges, there was a 
reduction of 41% by node and a 58% reduction by edge from the semantic 
optimization. This optimization likely influenced the occurrence of the sub-
networks by removing false positives.  In each of the four node networks, tested 
in the CA simulation of the Bcl2 family proteins, the occurrence in the apoptosis 
network was lower than the null hypothesis (mean occurrence in simulated 
random networks), the opposite occurred in the Autism network. The three 4-
node sub-networks are displayed in figures 18-21 (reproduced below). 
53 
 
 
 
 
 
Figure 24 – 4-Node, 4-Edge 
Non-Symmetrical Non-Linear 
Motif 
 
Figure 25 – 4-Node, 4-Edge 
Symmetrical Non-Linear Bi-Fan 
Motif 
 
Figure 26 – 4-Node, 4-Edge Bi-
parallel Motif 
 
Figure 27 – 6-Node, 9-Edge Tri-parallel Motif 
 
Figure 28 – 5-Node, 6-Edge Tri-parallel Motif 
 
The motif in Figure 18 occurred at a ratio of 0.10 (ratio = (observed in 
network)/(mean occurrence in random networks)) in the Apoptosis network, 
versus 1.62 in the Autism network. This pattern continues through the motif in 
Figure 20 where the apoptosis network had a ratio of 0.67, vs. 2.07 in the Autism 
network. It also occurs in the motif in Figure 19 where the apoptosis network had 
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a ratio of 0.04, compared to 5.41 in the Autism network. Additionally this 
continued in the 6-node, 9-edge motif in Figure 21. The motif in Figure 22 could 
not be compared, because it was not significant in the apoptosis network, but the 
pattern remained in the Autism one.  
The ratio of the motifs found in apoptosis (Table 7), were consistently low 
in apoptosis and consistently high in the autism network. The consistency of 
these results suggests there are fundamental differences in the apoptosis 
signaling and autism networks. Apoptosis has been studied in detail for decades, 
producing a wealth of interaction data available in the databases used in this 
study. Autism has only recently received attention and little of the pathogenicity 
of autism is understood. The apoptosis network needed to be normalized to 
remove the noise of repeat or irrelevant data that was produced by a basic 
search that yielded more proteins than could occur naturally. Autism required 
multiple search attempts revealing a single data-source of uncurated metadata. A 
possible reason for this inconsistency is the apoptosis signaling network is 
focused on one group of functions, those of cell death through apoptosis, and it is 
well understood and heavily studied.  The autism network is likely a mix of 
functional groups and is still very incomplete. In apoptosis, these motifs do 
represent regions of functional control and therefore occur at a lower ratio when 
compared to random networks. In Autism these motifs are over represented 
because Autism is associated with a mix of functional groups and the network is 
incomplete. Additionally, in autism these motifs are occurring at a higher ratio 
because their role in controlling signaling and pathway selection/function 
increases the likelihood they are observed during the onset of autism. 
Based on this result, the ratio of motifs could be used to identify whether a 
larger network represents more than one functional group, possibly as a measure 
of biomolecular network completeness. Although this is not evidence the 
hypothesis holds true, this study suggests the ratio of these motifs area a 
reporter for the presence or absence of functional groups in larger biomolecular 
networks. 
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Future work 
 In order to understand the entire role of each of these motifs that hint at 
function, a study of the expression of their associated genes and proteins needs 
to be done. This would require the creation of a software based tool that will 
extract expression data from a data-source, calculate the average across all 
related disease types and stages, and then compare the ratio of occurrence of 
the motif with the expression of each gene and protein represented in the 
network. Cytoscape’s NetMatch would be an excellent tool because it has the 
ability to report the identity of each motif, even with over-represented interactions 
(where more than one edge is present between two nodes). The result of this 
study would be a list of network motifs and genes/proteins that would increase 
the likelihood for the network to be complete, and whether it includes few or 
many functional groups. This would be a significant expansion of the use of 
network motifs in studying biomolecular networks and their control of cell function 
and disease. 
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develop an open source curated bioinformatics database of human pathways and 
reactions. Recently, we developed a new web site with improved tools for 
pathway browsing and data analysis. The Pathway Browser is an Systems Biology 
Graphical Notation (SBGN)-based visualization system that supports zooming, 
scrolling and event highlighting. It exploits PSIQUIC web services to overlay our 
curated pathways with molecular interaction data from the Reactome Functional 
Interaction Network and external interaction databases such as IntAct, BioGRID, 
ChEMBL, iRefIndex, MINT and STRING. Our Pathway and Expression Analysis 
tools enable ID mapping, pathway assignment and overrepresentation analysis of 
user-supplied data sets. To support pathway annotation and analysis in other 
species, we continue to make orthology-based inferences of pathways in non-
human species, applying Ensembl Compara to identify orthologs of curated 
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human proteins in each of 20 other species. The resulting inferred pathway sets 
can be browsed and analyzed with our Species Comparison tool. Collaborations 
are also underway to create manually curated data sets on the Reactome 
framework for chicken, Drosophila and rice. 
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Rev E Stat Nonlin Soft Matter Phys 68(4 Pt 2): 046109. 
 We propose a general approach to the description of spectra of complex networks. 
For the spectra of networks with uncorrelated vertices (and a local treelike 
structure), exact equations are derived. These equations are generalized to the 
case of networks with correlations between neighboring vertices. The tail of the 
density of eigenvalues rho(lambda) at large /lambda/ is related to the behavior of 
the vertex degree distribution P(k) at large k. In particular, as P(k) approximately 
k(-gamma), rho(lambda) approximately /lambda/(1-2 gamma). We propose a 
simple approximation, which enables us to calculate spectra of various graphs 
analytically. We analyze spectra of various complex networks and discuss the role 
of vertices of low degree. We show that spectra of locally treelike random graphs 
may serve as a starting point in the analysis of spectral properties of real-world 
networks, e.g., of the Internet. 
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biological networks." Bioinformatics 23(7): 910-2. 
 NetMatch is a Cytoscape plugin which allows searching biological networks for 
subcomponents matching a given query. Queries may be approximate in the sense 
that certain parts of the subgraph-query may be left unspecified. To make the 
query creation process easy, a drawing tool is provided. Cytoscape is a 
bioinformatics software platform for the visualization and analysis of biological 
networks. AVAILABILITY: The full package, a tutorial and associated examples 
are available at the following web sites: 
http://alpha.dmi.unict.it/~ctnyu/netmatch.html, 
http://baderlab.org/Software/NetMatch. 
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and dysplastic syndromes." Hum Mol Genet 14 Spec No 1: R85-92. 
 Inactivation of tumour suppressor genes is central to the development of cancer. 
Although this inactivation was once considered to be secondary to intragenic 
mutations, it is now clear that silencing of these genes often occurs by epigenetic 
means. Hypermethylation of CpG islands associated with the tumour suppressor 
genes was the first manifestation of this phenomenon to be described. It is 
apparent, however, that this is one of a host of chromatin modifications which 
characterize gene silencing. Although we know little about what determines 
which loci are affected, our understanding of the nature of the epigenetic marks 
and how they are established has blossomed. There is no compelling evidence that 
cancer ever develops by purely epigenetic means, but it is apparent that 
perturbations in the apparatus which establish the epigenome may contribute to 
the development of cancer. This review will focus on the role of two classes of 
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chromatin remodelling enzymes, those that alter histones by the addition or 
removal of acetyl and methyl groups and those of the SWI/SNF family of proteins 
that change the topology of the nucleosome and its DNA strand via the hydrolysis 
of ATP, and we shall examine the consequence of mutations in, or mis-expression 
of, these factors. In some cases, mutations in these factors appear to play a direct 
role in cancer development. However, their general role as important 
intermediaries involved in regulating gene expression makes them attractive 
therapeutic targets. In exciting developments, it has been shown that inhibition of 
these factors leads to the reversal of tumour suppressor gene silencing and the 
inhibition of cancer cell growth. 
 
Goll, J., S. V. Rajagopala, et al. (2008). "MPIDB: the microbial protein interaction 
database." Bioinformatics 24(15): 1743-4. 
 SUMMARY: The microbial protein interaction database (MPIDB) aims to collect 
and provide all known physical microbial interactions. Currently, 22,530 
experimentally determined interactions among proteins of 191 bacterial 
species/strains can be browsed and downloaded. These microbial interactions 
have been manually curated from the literature or imported from other databases 
(IntAct, DIP, BIND, MINT) and are linked to 24,060 experimental evidences 
(PubMed ID, PSI-MI methods). In contrast to these databases, interactions in 
MPIDB are further supported by 8150 additional evidences based on interaction 
conservation, co-purification and 3D domain contacts (iPfam, 3did). 
AVAILABILITY: http://www.jcvi.org/mpidb/ 
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Jourdan, M., T. Reme, et al. (2009). "Gene expression of anti- and pro-apoptotic proteins 
in malignant and normal plasma cells." Br J Haematol 145(1): 45-58. 
 The survival of malignant plasma cells is a key event in disease occurrence, 
progression and chemoresistance. Using DNA-microarrays, we analysed the 
expression of genes coding for 58 proteins linked with extrinsic and intrinsic 
apoptotic pathways, caspases and inhibitor of apoptosis proteins. We considered 
six memory B cells (MBC), seven plasmablasts (PPC), seven bone marrow 
plasma cells (BMPC) and purified myeloma cells (MMC) from 92 newly-
diagnosed patients. Forty out of the 58 probe sets enabled the separation of MBC, 
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PPC and BMPC in three homogeneous clusters, characterized by an elevated 
expression of TNFRSF10A, TNFRSF10B, BCL2A1, CASP8, CASP9 and 
PMAIP1 genes for MBC, of FAS, FADD, AIFM1, BIRC5, CASP CASP2, 
CASP3 and CASP6 for PPC and of BCL2, MCL1, BID, BIRC3 and XIAP for 
BMPC. Thus, B cell differentiation was associated with change of expression of 
pro-apoptotic and anti-apoptotic genes. Regarding MMC, the major finding was 
TRAIL upregulation that might be counteracted by a high osteoprotegerin 
production by BM stromal cells and a decreased expression of FAS, APAF1 and 
BNIP3 compared to normal BMPC. Out of the 40 genes, CASP2 and BIRC5 
expression in MMC had adverse prognosis in two independent series of 
previously-untreated patients. 
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 IntAct is an open source database and software suite for modeling, storing and 
analyzing molecular interaction data. The data available in the database originates 
entirely from published literature and is manually annotated by expert biologists 
to a high level of detail, including experimental methods, conditions and 
interacting domains. The database features over 126,000 binary interactions 
extracted from over 2100 scientific publications and makes extensive use of 
controlled vocabularies. The web site provides tools allowing users to search, 
visualize and download data from the repository. IntAct supports and encourages 
local installations as well as direct data submission and curation collaborations. 
IntAct source code and data are freely available from http://www.ebi.ac.uk/intact. 
 
Kier, L. B. (2008). "A review of recent studies relating ligand diffusion, general 
anesthesia, and sleep." AANA J 76(2): 109-12. 
 This review article presents 3 theories related to ligand diffusion, general 
anesthesia and sleep. The first theory describes the diffusion of molecules across a 
protein surface to a receptor. It is based on the effect of the amino acid side chains 
on the protein surface on the structure of bulk water nearby. This influence creates 
pathways, called chreodes, through the water near the protein surface, permitting 
a rapid diffusion of molecules to the receptors. A second theory involving the role 
of chreodes presents a mechanism of action of nonspecific anesthetic agents. 
These agents interrupt the diffusion of neurotransmitter molecules to their 
receptors, bringing on the anesthetic effects. Finally, building on the similarities 
of anesthesia and sleep, a theory is presented proposing that an external agent 
influences sleep in a way similar to that of the nonspecific anesthetic molecules. 
This external agent is proposed to be elemental nitrogen. Several observations are 
presented to support this mechanism. 
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 The potential of the cellular-automata (CA) method for modeling biological 
networks is demonstrated for the mitogen-activated protein kinase (MAPK) 
signaling cascade. The models derived reproduced the high signal amplification 
through the cascade and the deviation of the cascade enzymes from the Michaelis-
Menten kinetics, evidencing cooperativity effects. The patterns of pathway 
change upon varying substrate concentrations and enzyme efficiencies were 
identified and used to show the ways for controlling pathway processes. Guidance 
in the selection of enzyme inhibition targets with minimum side effects is one 
outcome of the study. 
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Systems, Springer. 
  
Kuznetsov, V., S. Thomas, et al. (2008). "Data-driven Networking Reveals 5-Genes 
Signature for Early Detection of Lung Cancer." 2008 International Conference on 
BioMedical Engineering and Informatics 1: 413-417. 
  
Medina, P. P., J. Carretero, et al. (2005). "Transcriptional targets of the chromatin-
remodelling factor SMARCA4/BRG1 in lung cancer cells." Hum Mol Genet 14(7): 973-
82. 
 BRG1, also called SMARCA4, is the catalytic subunit of the SWI/SNF 
chromatin-remodelling complex and influences transcriptional regulation by 
disrupting histone-DNA contacts in an ATP-dependent manner. BRG1 and other 
members of the SWI/SNF complex become inactivated in tumours, implying a 
role in cancer development. To understand the contribution of BRG1 to lung 
tumourigenesis, we restored BRG1 in H1299 lung cancer cells and used cDNA 
microarray analysis to identify changes in gene expression. Forty-three transcripts 
became activated, whereas two were repressed. Chromatin immunoprecipitation 
of resulting candidate genes revealed that the CYP3A4 and ZNF185 promoters 
recruited BRG1 and that recruitment to the CYP3A4 promoter was specific to this 
gene and did not involve the CYP3A5 or CYP3A7 family members. Moreover, 
specifically BRG1 but not its homologue BRM was recruited to the CYP3A4 and 
ZNF185 promoters. To explore their potential relevance in lung tumours, levels of 
CYP3A4 and ZNF185 transcripts were evaluated in seven additional lung cancer 
cell lines. CYP3A4 was undetectable in any of the lung cancer cells tested, and 
only the CYP3A5 family member was present in the A549 and Calu-3 cells. In 
contrast, the amount of ZNF185 transcript clearly varied among lung cancer cell 
lines and severely reduced levels were observed in BRG1-deficient cells, except 
those of A427. We extended these observations to 27 lung primary tumours using 
real-time RT-PCR (TaqMan) and observed that four (15%) and 14 (52%) of them 
had BRG1 and ZNF185 downregulation, respectively, when compared with 
normal lung. No significant correlation between reduced levels of BRG1 and 
ZNF185 was observed, indicating that additional mechanisms to BRG1 
inactivation may contribute to the loss of ZNF185 expression in lung tumours. In 
conclusion, our results provide evidence that transcriptional activation of ZNF185 
and CYP3A4 is mediated by direct association of BRG1 with their promoters and 
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also indicate that a decreased level of ZNF185 is a common feature of lung 
tumours and may be of biological relevance in lung carcinogenesis. 
 
Milo, R., S. Shen-Orr, et al. (2002). "Network motifs: simple building blocks of complex 
networks." Science 298(5594): 824-7. 
 Complex networks are studied across many fields of science. To uncover their 
structural design principles, we defined "network motifs," patterns of 
interconnections occurring in complex networks at numbers that are significantly 
higher than those in randomized networks. We found such motifs in networks 
from biochemistry, neurobiology, ecology, and engineering. The motifs shared by 
ecological food webs were distinct from the motifs shared by the genetic networks 
of Escherichia coli and Saccharomyces cerevisiae or from those found in the 
World Wide Web. Similar motifs were found in networks that perform 
information processing, even though they describe elements as different as 
biomolecules within a cell and synaptic connections between neurons in 
Caenorhabditis elegans. Motifs may thus define universal classes of networks. 
This approach may uncover the basic building blocks of most networks. 
 
Montecchi-Palazzi, L., S. Kerrien, et al. (2009). "The PSI semantic validator: a 
framework to check MIAPE compliance of proteomics data." Proteomics 9(22): 5112-9. 
 The Human Proteome Organization's Proteomics Standards Initiative (PSI) 
promotes the development of exchange standards to improve data integration and 
interoperability. PSI specifies the suitable level of detail required when reporting 
a proteomics experiment (via the Minimum Information About a Proteomics 
Experiment), and provides extensible markup language (XML) exchange formats 
and dedicated controlled vocabularies (CVs) that must be combined to generate a 
standard compliant document. The framework presented here tackles the issue of 
checking that experimental data reported using a specific format, CVs and public 
bio-ontologies (e.g. Gene Ontology, NCBI taxonomy) are compliant with the 
Minimum Information About a Proteomics Experiment recommendations. The 
semantic validator not only checks the XML syntax but it also enforces rules 
regarding the use of an ontology class or CV terms by checking that the terms 
exist in the resource and that they are used in the correct location of a document. 
Moreover, this framework is extremely fast, even on sizable data files, and 
flexible, as it can be adapted to any standard by customizing the parameters it 
requires: an XML Schema Definition, one or more CVs or ontologies, and a 
mapping file describing in a formal way how the semantic resources and the 
format are interrelated. As such, the validator provides a general solution to the 
common problem in data exchange: how to validate the correct usage of a data 
standard beyond simple XML Schema Definition validation. The framework 
source code and its various applications can be found at 
http://psidev.info/validator. 
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Semantic Web Architecture and Protocol (SSWAP) for bioinformatics resource discovery 
and disparate data and service integration." BioData Min 3(1): 3. 
66 
 
 
 
 
 ABSTRACT: BACKGROUND: Scientific data integration and computational 
service discovery are challenges for the bioinformatic community. This process is 
made more difficult by the separate and independent construction of biological 
databases, which makes the exchange of data between information resources 
difficult and labor intensive. A recently described semantic web protocol, the 
Simple Semantic Web Architecture and Protocol (SSWAP; pronounced "swap") 
offers the ability to describe data and services in a semantically meaningful way. 
We report how three major information resources (Gramene, SoyBase and the 
Legume Information System [LIS]) used SSWAP to semantically describe 
selected data and web services. METHODS: We selected high-priority 
Quantitative Trait Locus (QTL), genomic mapping, trait, phenotypic, and 
sequence data and associated services such as BLAST for publication, data 
retrieval, and service invocation via semantic web services. Data and services 
were mapped to concepts and categories as implemented in legacy and de novo 
community ontologies. We used SSWAP to express these offerings in OWL Web 
Ontology Language (OWL), Resource Description Framework (RDF) and 
eXtensible Markup Language (XML) documents, which are appropriate for their 
semantic discovery and retrieval. We implemented SSWAP services to respond to 
web queries and return data. These services are registered with the SSWAP 
Discovery Server and are available for semantic discovery at http://sswap.info. 
RESULTS: A total of ten services delivering QTL information from Gramene 
were created. From SoyBase, we created six services delivering information about 
soybean QTLs, and seven services delivering genetic locus information. For LIS 
we constructed three services, two of which allow the retrieval of DNA and RNA 
FASTA sequences with the third service providing nucleic acid sequence 
comparison capability (BLAST). CONCLUSIONS: The need for semantic 
integration technologies has preceded available solutions. We report the 
feasibility of mapping high priority data from local, independent, idiosyncratic 
data schemas to common shared concepts as implemented in web-accessible 
ontologies. These mappings are then amenable for use in semantic web services. 
Our implementation of approximately two dozen services means that biological 
data at three large information resources (Gramene, SoyBase, and LIS) is 
available for programmatic access, semantic searching, and enhanced interaction 
between the separate missions of these resources. 
 
Neumann, J. V. and A. W. Burks (1966). Theory of Self-Reproducing Automata. Urbana 
and London, University of Illinois Press. 
  
Nikitin, A., S. Egorov, et al. (2003). "Pathway studio--the analysis and navigation of 
molecular networks." Bioinformatics 19(16): 2155-7. 
 SUMMARY: PathwayAssist is a software application developed for navigation 
and analysis of biological pathways, gene regulation networks and protein 
interaction maps. It comes with the built-in natural language processing module 
MedScan and the comprehensive database describing more than 100 000 events 
of regulation, interaction and modification between proteins, cell processes and 
small molecules. AVAILABILITY: PathwayAssist is available for commercial 
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licensing from Ariadne Genomics, Inc. The light version with limited 
functionality will be available for free for academic users at 
www.ariadnegenomics.com/downloads/. 
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Razick, S., G. Magklaras, et al. (2008). "iRefIndex: a consolidated protein interaction 
database with provenance." BMC Bioinformatics 9: 405. 
 BACKGROUND: Interaction data for a given protein may be spread across 
multiple databases. We set out to create a unifying index that would facilitate 
searching for these data and that would group together redundant interaction data 
while recording the methods used to perform this grouping. RESULTS: We 
present a method to generate a key for a protein interaction record and a key for 
each participant protein. These keys may be generated by anyone using only the 
primary sequence of the proteins, their taxonomy identifiers and the Secure Hash 
Algorithm. Two interaction records will have identical keys if they refer to the 
same set of identical protein sequences and taxonomy identifiers. We define 
records with identical keys as a redundant group. Our method required that we 
map protein database references found in interaction records to current protein 
sequence records. Operations performed during this mapping are described by a 
mapping score that may provide valuable feedback to source interaction databases 
on problematic references that are malformed, deprecated, ambiguous or unfound. 
Keys for protein participants allow for retrieval of interaction information 
independent of the protein references used in the original records. 
CONCLUSION: We have applied our method to protein interaction records from 
BIND, BioGrid, DIP, HPRD, IntAct, MINT, MPact, MPPI and OPHID. The 
resulting interaction reference index is provided in PSI-MITAB 2.5 format at 
http://irefindex.uio.no. This index may form the basis of alternative redundant 
groupings based on gene identifiers or near sequence identity groupings. 
 
Reisman, D. N., J. Sciarrotta, et al. (2003). "Loss of BRG1/BRM in human lung cancer 
cell lines and primary lung cancers: correlation with poor prognosis." Cancer Res 63(3): 
560-6. 
 A role for the SWI/SNF complex in tumorigenesis based on its requirement for 
retinoblastoma induced growth arrest and p53-mediated transcription and the 
appearance of tumors in SWI/SNF-deficient mice. In addition, Western blot data 
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have shown that the SWI/SNF ATPase subunits cell, BRG1 and BRM 
(BRG1/BRM), are lost in approximately 30% of human non-small lung cancer 
cell lines. To determine whether loss of expression of these proteins occurs in 
primary tumors, we examined their expression in 41 primary lung 
adenocarcinomas and 19 primary lung squamous carcinomas by 
immunohistochemistry. These analyses showed that 10% of tumors show a 
concomitant loss of BRG1 and BRM expression. Moreover, patients with 
BRG1/BRM-negative carcinomas, independent of stage, have a statistically 
significant decrease in survival compared with patients with BRG1/BRM. This 
report provides supportive evidence that BRG1 and BRM act as tumor suppressor 
proteins and implicates a role for their loss in the development of non-small cell 
lung cancers. 
 
Renouf, D. J., R. Wood-Baker, et al. (2009). "BCL-2 expression is prognostic for 
improved survival in non-small cell lung cancer." J Thorac Oncol 4(4): 486-91. 
 OBJECTIVE: We used a large patient population to identify 
immunohistochemical biomarkers to enable improved prognostication in patients 
with non-small cell lung carcinoma (NSCLC). METHODS: A tissue microarray 
was constructed using duplicate 0.6 mm cores of formalin-fixed paraffin-
embedded tissue blocks from 609 patients with NSCLC. Immunohistochemical 
was used to detect 11 biomarkers including epidermal growth factor receptor, 
Her2, Her3, p53, p63, bcl-1, bcl-2, Thyroid transcription factor, carcinoembryonic 
antigen, chromogranin, and synaptophysin. A clinical database was generated 
prospectively at the time of tissue collection. Survival outcomes were obtained 
from a Provincial Cancer Registry database. Univariate and multivariate analyses 
were performed to look for a relationship between biomarker expression, smoking 
history, and survival. RESULTS: Survival data for 535 cases were available. As 
of June 2005, 429 patients (80%) had died; of these 286 (54%) died of lung 
cancer, 117 (22%) died of other known causes, and for 26 (5%) the cause of death 
was not available. Univariate analysis revealed that bcl-2 (p = 0.007) was the only 
biomarker prognostic for improved overall survival (OS). bcl-2 (p = 0.021) and 
p63 (p = 0.025) were both found to be prognostic for improved disease-specific 
survival (DSS). Multivariate analysis (using age and biomarker expression) 
revealed that bcl-2 expression is prognostic for improved OS (p = 0.005) and DSS 
(p = 0.021). CONCLUSIONS: Our results suggest that bcl-2 expression is 
prognostic for improved OS and DSS in NSCLC. Testing for bcl-2 expression in a 
prospective study will help to determine its clinical relevance in prognostication. 
 
Rhodes, D. R., S. Kalyana-Sundaram, et al. (2007). "Oncomine 3.0: genes, pathways, and 
networks in a collection of 18,000 cancer gene expression profiles." Neoplasia 9(2): 166-
80. 
 DNA microarrays have been widely applied to cancer transcriptome analysis; 
however, the majority of such data are not easily accessible or comparable. 
Furthermore, several important analytic approaches have been applied to 
microarray analysis; however, their application is often limited. To overcome 
these limitations, we have developed Oncomine, a bioinformatics initiative aimed 
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at collecting, standardizing, analyzing, and delivering cancer transcriptome data to 
the biomedical research community. Our analysis has identified the genes, 
pathways, and networks deregulated across 18,000 cancer gene expression 
microarrays, spanning the majority of cancer types and subtypes. Here, we 
provide an update on the initiative, describe the database and analysis modules, 
and highlight several notable observations. Results from this comprehensive 
analysis are available at http://www.oncomine.org. 
 
Rives, A. W. and T. Galitski (2003). "Modular organization of cellular networks." Proc 
Natl Acad Sci U S A 100(3): 1128-33. 
  
Sasaki, H., S. Moriyama, et al. (2004). "Histone deacetylase 1 mRNA expression in lung 
cancer." Lung Cancer 46(2): 171-8. 
 Histone deacetylases (HDACs) play a crucial role in tumorigenesis, however, the 
expression status of HDACs in lung cancer tissues has not been reported. We 
have investigated that HIDAC 1 mRNA levels and other clinico-pathological 
data, including MTA 1 mRNA expression in lung cancer. The study included 102 
lung cancer cases. The HDAC1 mRNA levels were quantified by real time 
reverse transcription-polymerase chain reaction (RT-PCR) using LightCycler 
(Roche Molecular Biochemicals, Mannheim, Germany). The HDAC1/GAPDH 
mRNA levels were not significantly different in tumor tissues from lung cancer 
(30.654 +/- 33.047) and adjacent non-malignant lung tissues (18.953 +/- 56.176 , 
P = 0.1827). No significant difference in HDAC1/GAPDH mRNA levels was 
found among age, gender, and lymph node metastasis. The HDAC1/GAPDH 
mRNA levels were significantly higher in stage III or IV lung cancer (50.929 +/- 
120.433) than in stage I lung cancer (11.430 +/- 25.611, P = 0.0472). 
HDAC1/GAPDH mRNA levels were significantly higher in T3 or T4 lung 
carcinoma (54.326 +/- 127.018) than in T1 or T2 lung cancers (14.790 +/- 48.670, 
P = 0.1601). HDAC1/GAPDH mRNA levels were correlated with 
MTA1/GAPDH mRNA levels (y = 0.0106x + 2.5827 , P = 0.0352 ). 
HDAC1/GAPDH mRNA levels were also correlated with HDAC1 protein (P = 
0.0484) expression by immunohistochemistry. Using the LightCycler RT-PCR 
assay, the HDAC1 gene expression might correlate with progression of lung 
cancers. However, further studies are needed to confirm the impact of HDAC1 for 
the molecular target of the lung cancer. 
 
Sayers, E. W., T. Barrett, et al. "Database resources of the National Center for 
Biotechnology Information." Nucleic Acids Res 38(Database issue): D5-16. 
 In addition to maintaining the GenBank nucleic acid sequence database, the 
National Center for Biotechnology Information (NCBI) provides analysis and 
retrieval resources for the data in GenBank and other biological data made 
available through the NCBI web site. NCBI resources include Entrez, the Entrez 
Programming Utilities, MyNCBI, PubMed, PubMed Central, Entrez Gene, the 
NCBI Taxonomy Browser, BLAST, BLAST Link (BLink), Electronic PCR, 
OrfFinder, Spidey, Splign, Reference Sequence, UniGene, HomoloGene, 
ProtEST, dbMHC, dbSNP, Cancer Chromosomes, Entrez Genomes and related 
70 
 
 
 
 
tools, the Map Viewer, Model Maker, Evidence Viewer, Trace Archive, Sequence 
Read Archive, Retroviral Genotyping Tools, HIV-1/Human Protein Interaction 
Database, Gene Expression Omnibus, Entrez Probe, GENSAT, Online Mendelian 
Inheritance in Man, Online Mendelian Inheritance in Animals, the Molecular 
Modeling Database, the Conserved Domain Database, the Conserved Domain 
Architecture Retrieval Tool, Biosystems, Peptidome, Protein Clusters and the 
PubChem suite of small molecule databases. Augmenting many of the web 
applications are custom implementations of the BLAST program optimized to 
search specialized data sets. All these resources can be accessed through the 
NCBI home page at www.ncbi.nlm.nih.gov. 
 
Scardoni, G., M. Petterlini, et al. (2009). "Analyzing biological network parameters with 
CentiScaPe." Bioinformatics 25(21): 2857-9. 
 SUMMARY: The increasing availability of large network datasets along with the 
progresses in experimental high-throughput technologies have prompted the need 
for tools allowing easy integration of experimental data with data derived form 
network computational analysis. In order to enrich experimental data with 
network topological parameters, we have developed the Cytoscape plug-in 
CentiScaPe. The plug-in computes several network centrality parameters and 
allows the user to analyze existing relationships between experimental data 
provided by the users and node centrality values computed by the plug-in. 
CentiScaPe allows identifying network nodes that are relevant from both 
experimental and topological viewpoints. CentiScaPe also provides a Boolean 
logic-based tool that allows easy characterization of nodes whose topological 
relevance depends on more than one centrality. Finally, different graphic outputs 
and the included description of biological significance for each computed 
centrality facilitate the analysis by the end users not expert in graph theory, thus 
allowing easy node categorization and experimental prioritization. 
AVAILABILITY: CentiScaPe can be downloaded via the Cytoscape web site: 
http://chianti.ucsd.edu/cyto_web/plugins/index.php. Tutorial, centrality 
descriptions and example data are available at: http://profs.sci.univr.it/ 
approximately scardoni/centiscape/centiscapepage.php CONTACT: 
giovanni.scardoni@gmail.com SUPPLEMENTARY INFORMATION: 
Supplementary data are available at Bioinformatics online. 
 
Sherman, B. T., W. Huang da, et al. (2007). "DAVID Knowledgebase: a gene-centered 
database integrating heterogeneous gene annotation resources to facilitate high-
throughput gene functional analysis." BMC Bioinformatics 8: 426. 
 BACKGROUND: Due to the complex and distributed nature of biological 
research, our current biological knowledge is spread over many redundant 
annotation databases maintained by many independent groups. Analysts usually 
need to visit many of these bioinformatics databases in order to integrate 
comprehensive annotation information for their genes, which becomes one of the 
bottlenecks, particularly for the analytic task associated with a large gene list. 
Thus, a highly centralized and ready-to-use gene-annotation knowledgebase is in 
demand for high throughput gene functional analysis. DESCRIPTION: The 
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DAVID Knowledgebase is built around the DAVID Gene Concept, a single-
linkage method to agglomerate tens of millions of gene/protein identifiers from a 
variety of public genomic resources into DAVID gene clusters. The grouping of 
such identifiers improves the cross-reference capability, particularly across NCBI 
and UniProt systems, enabling more than 40 publicly available functional 
annotation sources to be comprehensively integrated and centralized by the 
DAVID gene clusters. The simple, pair-wise, text format files which make up the 
DAVID Knowledgebase are freely downloadable for various data analysis uses. 
In addition, a well organized web interface allows users to query different types of 
heterogeneous annotations in a high-throughput manner. CONCLUSION: The 
DAVID Knowledgebase is designed to facilitate high throughput gene functional 
analysis. For a given gene list, it not only provides the quick accessibility to a 
wide range of heterogeneous annotation data in a centralized location, but also 
enriches the level of biological information for an individual gene. Moreover, the 
entire DAVID Knowledgebase is freely downloadable or searchable at 
http://david.abcc.ncifcrf.gov/knowledgebase/. 
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 BACKGROUND: Many of the functional units in cells are multi-protein 
complexes such as RNA polymerase, the ribosome, and the proteasome. For such 
units to work together, one might expect a high level of regulation to enable co-
appearance or repression of sets of complexes at the required time. However, this 
type of coordinated regulation between whole complexes is difficult to detect by 
existing methods for analyzing mRNA co-expression. We propose a new 
methodology that is able to detect such higher order relationships. RESULTS: We 
detect coordinated regulation of multiple protein complexes using logic analysis 
of gene expression data. Specifically, we identify gene triplets composed of genes 
whose expression profiles are found to be related by various types of logic 
functions. In order to focus on complexes, we associate the members of a gene 
triplet with the distinct protein complexes to which they belong. In this way, we 
identify complexes related by specific kinds of regulatory relationships. For 
example, we may find that the transcription of complex C is increased only if the 
transcription of both complex A AND complex B is repressed. We identify 
hundreds of examples of coordinated regulation among complexes under various 
stress conditions. Many of these examples involve the ribosome. Some of our 
examples have been previously identified in the literature, while others are novel. 
One notable example is the relationship between the transcription of the ribosome, 
RNA polymerase and mannosyltransferase II, which is involved in N-linked 
glycan processing in the Golgi. CONCLUSIONS: The analysis proposed here 
focuses on relationships among triplets of genes that are not evident when genes 
are examined in a pairwise fashion as in typical clustering methods. By grouping 
gene triplets, we are able to decipher coordinated regulation among sets of three 
complexes. Moreover, using all triplets that involve coordinated regulation with 
the ribosome, we derive a large network involving this essential cellular complex. 
In this network we find that all multi-protein complexes that belong to the same 
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database that archives and disseminates genetic and protein interaction data from 
model organisms and humans (http://www.thebiogrid.org). BioGRID currently 
holds 347 966 interactions (170 162 genetic, 177 804 protein) curated from both 
high-throughput data sets and individual focused studies, as derived from over 23 
000 publications in the primary literature. Complete coverage of the entire 
literature is maintained for budding yeast (Saccharomyces cerevisiae), fission 
yeast (Schizosaccharomyces pombe) and thale cress (Arabidopsis thaliana), and 
efforts to expand curation across multiple metazoan species are underway. The 
BioGRID houses 48 831 human protein interactions that have been curated from 
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biology to enable insights into conserved networks and pathways that are relevant 
to human health. The BioGRID 3.0 web interface contains new search and display 
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PANTHER is composed of two main components: the PANTHER library 
(PANTHER/LIB) and the PANTHER index (PANTHER/X). PANTHER/LIB is a 
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based on shared function, and by subtree HMMs. PANTHER/X is an abbreviated 
ontology for summarizing and navigating molecular functions and biological 
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Second, we use the PANTHER/X ontology to give a high-level representation of 
gene function across the human and mouse genomes. Third, we use the family 
HMMs to rank missense single nucleotide polymorphisms (SNPs), on a database-
wide scale, according to their likelihood of affecting protein function. 
 
Thomas, S. W. (2008). "Network Builder 1.-." USPTO Application. 
  
Walker, S. J., J. Segal, et al. (2006). "Cultured lymphocytes from autistic children and 
non-autistic siblings up-regulate heat shock protein RNA in response to thimerosal 
challenge." Neurotoxicology 27(5): 685-92. 
  
Wall, D. P., F. J. Esteban, et al. (2009). "Comparative analysis of neurological disorders 
focuses genome-wide search for autism genes." Genomics 93(2): 120-9. 
 The behaviors of autism overlap with a diverse array of other neurological 
disorders, suggesting common molecular mechanisms. We conducted a large 
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neurological disorders. 
 
Wernicke, S. and F. Rasche (2006). "FANMOD: a tool for fast network motif detection." 
Bioinformatics 22(9): 1152-3. 
 SUMMARY: Motifs are small connected subnetworks that a network displays in 
significantly higher frequencies than would be expected for a random network. 
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 Gene expression profiling provides unprecedented opportunities to study patterns 
of gene expression regulation, for example, in diseases or developmental 
processes. Bioinformatics analysis plays an important part of processing the 
information embedded in large-scale expression profiling studies and for laying 
the foundation for biological interpretation. Over the past years, numerous tools 
have emerged for microarray data analysis. One of the most popular platforms is 
Bioconductor, an open source and open development software project for the 
analysis and comprehension of genomic data, based on the R programming 
language. In this chapter, we use Bioconductor analysis packages on a heart 
development dataset to demonstrate the workflow of microarray data analysis 
from annotation, normalization, expression index calculation, and diagnostic plots 
to pathway analysis, leading to a meaningful visualization and interpretation of 
the data. 
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